Marimed (MRMD) Net Income Growth (3y) (2014 - 2026)
Marimed (MRMD) Net Income Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.69 Bn | 87.82 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 51.28% |
| 3 | Zoetis | 32.57 Bn | 30.63 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -62.58% |
| 5 | United Therapeutics | 23.08 Bn | 20.93 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 22.43 Bn | 22.43 Bn | - | - |
| 7 | Viatris | 20.23 Bn | 18.42 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn | -17.90% |
| 10 | Marimed | 25.72 Mn | 17.78 Mn | 15.28 Mn | -78.35% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.35% |
| Dec 31, 2025 | -43.86% |
| Sep 30, 2025 | -45.50% |
| Jun 30, 2025 | -38.73% |
| Mar 31, 2025 | -48.76% |
| Dec 31, 2024 | -8.86% |
| Sep 30, 2024 | -35.11% |
| Jun 30, 2024 | -30.37% |
| Mar 31, 2024 | -32.00% |
| Dec 31, 2023 | -53.47% |
| Sep 30, 2023 | -65.31% |
| Jun 30, 2023 | 6.43% |
| Mar 31, 2023 | 34.27% |
| Dec 31, 2022 | 27.24% |
| Sep 30, 2022 | 33.38% |
| Jun 30, 2022 | -26.23% |
| Mar 31, 2022 | 62.05% |
| Dec 31, 2021 | -12.96% |
| Sep 30, 2021 | 37.90% |
| Jun 30, 2021 | 177.31% |